17 results
6-K
ENLV
Enlivex Therapeutics Ltd
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
under the heading “Board Practices, Corporate Governance and Compensation of Executive Officers and Directors” in Exhibit 99.1 is incorporated
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
Underrepresented Individual in Home Country Jurisdiction
LGBTQ+
Did Not Disclose Demographic Background
Board Practices, Corporate Governance … committees and our corporate governance practices. We encourage you to review those portions of our 2022 Form 20-F.
PROPOSAL 1
ELECTION OF DIRECTORS
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
in Home Country Jurisdiction
LGBTQ+
Did Not Disclose Demographic Background
Board Practices, Corporate Governance and Compensation of Executive … . Item 6.C of our 2021 Form 20-F (“Board Practices”) contains additional information regarding our Board of Directors, its committees and our corporate
20-F/A
2018 FY
ENLV
Enlivex Therapeutics Ltd
23 Jan 20
Annual report (foreign) (amended)
4:31pm
. - “Corporate Governance - Approval of Related Party Transactions under Israeli law”);
examining our internal controls and internal auditor’s performance … .
CORPORATE GOVERNANCE
The Sarbanes-Oxley Act, as well as related rules subsequently implemented by the SEC, requires foreign private issuers, such as us
F-1/A
857biip1xp9cy1tgl9f0
8 Jul 14
Registration statement (foreign) (amended)
12:00am
424B4
nkge1 6shsk
31 Jul 14
Prospectus supplement with pricing info
12:00am
20-F
8xaj5le ezwedv
31 Mar 15
Annual report (foreign)
12:00am
6-K
EX-99.2
oow2s0c psuo
19 Nov 18
Agreement and Plan of Merger
4:34pm
- Prev
- 1
- Next